|
1
|
Collins AJ, Foley RN, Chavers B, et al:
United States Renal Data System 2011 Annual Data Report: Atlas of
chronic kidney disease & end-stage renal disease in the United
States. Am J Kidney Dis. 59(Suppl 1): A7e1–e420. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yanagita M: Inhibitors/antagonists of
TGF-beta system in kidney fibrosis. Nephrol Dial Transplant.
27:3686–3691. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hodgkins KS and Schnaper HW:
Tubulointerstitial injury and the progression of chronic kidney
disease. Pediatr Nephrol. 27:901–909. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Formentini I, Bobadilla M, Haefliger C, et
al: Current drug development challenges in chronic kidney disease
(CKD) - identification of individualized determinants of renal
progression and premature cardiovascular disease (CVD). Nephrol
Dial Transplant. 27(Suppl 3): iii81–iii88. 2012.
|
|
5
|
Barnes JL and Glass WF II: Renal
interstitial fibrosis: a critical evaluation of the origin of
myofibroblasts. Contrib Nephrol. 169:73–93. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grande MT and López-Novoa JM: Fibroblast
activation and myofibroblast generation in obstructive nephropathy.
Nat Rev Nephrol. 5:319–328. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Strutz F and Zeisberg M: Renal fibroblasts
and myofibroblasts in chronic kidney disease. J Am Soc Nephrol.
17:2992–2998. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
López-Hernández FJ and López-Novoa JM:
Role of TGF-beta in chronic kidney disease: an integration of
tubular, glomerular and vascular effects. Cell Tissue Res.
347:141–154. 2012.PubMed/NCBI
|
|
9
|
Verrecchia F and Mauviel A: Transforming
growth factor-beta signaling through the Smad pathway: role in
extracellular matrix gene expression and regulation. J Invest
Dermatol. 118:211–215. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Santibañez JF, Quintanilla M and Bernabeu
C: TGF-beta/TGF-beta receptor system and its role in physiological
and pathological conditions. Clin Sci (Lond). 121:233–251.
2011.PubMed/NCBI
|
|
11
|
Lan HY: Diverse roles of TGF-β/Smads in
renal fibrosis and inflammation. Int J Biol Sci. 7:1056–1067.
2011.
|
|
12
|
Kavitha CV, Agarwal C, Agarwal R and Deep
G: Asiatic acid inhibits pro-angiogenic effects of VEGF and human
gliomas in endothelial cell culture models. PLoS One. 6:e227452011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee KY, Bae ON, Serfozo K, et al: Asiatic
acid attenuates infarct volume, mitochondrial dysfunction, and
matrix metalloproteinase-9 induction after focal cerebral ischemia.
Stroke. 43:1632–1638. 2012.PubMed/NCBI
|
|
14
|
Tang LX, He RH, Yang G, et al: Asiatic
acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in
vivo and in vitro. PLoS One. 7:e313502012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang X, Wu J, Dou Y, et al: Asiatic acid
protects primary neurons against C2-ceramide-induced apoptosis. Eur
J Pharmacol. 679:51–59. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Eddy AA, López-Guisa JM, Okamura DM and
Yamaguchi I: Investigating mechanisms of chronic kidney disease in
mouse models. Pediatr Nephrol. 27:1233–1247. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Grande MT, Fuentes-Calvo I, Arévalo M, et
al: Deletion of H-Ras decreases renal fibrosis and myofibroblast
activation following ureteral obstruction in mice. Kidney Int.
77:509–518. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fujiu K, Manabe I and Nagai R: Renal
collecting duct epithelial cells regulate inflammation in
tubulointerstitial damage in mice. J Clin Invest. 121:3425–3441.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sörensen I, Susnik N, Inhester T, et al:
Fibrinogen, acting as a mitogen for tubulointerstitial fibroblasts,
promotes renal fibrosis. Kidney Int. 80:1035–1044. 2011.PubMed/NCBI
|
|
20
|
Barnes JL and Gorin Y: Myofibroblast
differentiation during fibrosis: role of NAD(P)H oxidases. Kidney
Int. 79:944–956. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Prunotto M, Budd DC, Gabbiani G, et al:
Epithelial-mesenchymal crosstalk alteration in kidney fibrosis. J
Pathol. 228:131–147. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zeisberg M and Neilson EG: Mechanisms of
tubulointerstitial fibrosis. J Am Soc Nephrol. 21:1819–1834. 2010.
View Article : Google Scholar
|
|
23
|
Mimura I and Nangaku M: The suffocating
kidney: tubulointerstitial hypoxia in end-stage renal disease. Nat
Rev Nephrol. 6:667–678. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Loeffler I, Liebisch M and Wolf G:
Collagen VIII influences epithelial phenotypic changes in
experimental diabetic nephropathy. Am J Physiol Renal Physiol.
303:F733–F745. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schaefer L: Extracellular matrix
molecules: endogenous danger signals as new drug targets in kidney
diseases. Curr Opin Pharmacol. 10:185–190. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Boor P and Floege J: The renal
(myo-)fibroblast: a heterogeneous group of cells. Nephrol Dial
Transplant. 27:3027–3036. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Boor P, Ostendorf T and Floege J: Renal
fibrosis: novel insights into mechanisms and therapeutic targets.
Nat Rev Nephrol. 6:643–656. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gewin L and Zent R: How does TGF-beta
mediate tubulointerstitial fibrosis? Semin Nephrol. 32:228–235.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Meng XM, Chung AC and Lan HY: Role of the
TGF-beta/BMP-7/Smad pathways in renal diseases. Clin Sci (Lond).
124:243–254. 2013. View Article : Google Scholar : PubMed/NCBI
|
